ArticleMalawi medical journal : the journal of Medical Association of Malawi2025
Barriers and Enablers to All-Oral Multi-Drug Resistance Tuberculosis Treatment Adherence in Traditional Authorities Chimwala and Chowe, Mangochi District, Malawi.
Article in Malawi medical journal : the journal of Medical Association of Malawi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Malawi National Tuberculosis Program (MNTP) switched the MDR-TB treatment regimen from a combination of injectable and oral anti-TB drugs to an all-oral regimen in 2018. This has increased the pill burden and increased the treatment period from 12 to 18 months. The change was necessitated by the need to minimize amikacin-induced side effects which include vertigo, convulsions, and numbness. However, the longer treatment period and pill burden may affect treatment adherence. Objective: The purpose of the study was to assess factors that influence adherence to the all-oral drugs for MDR-TB. Methods: This descriptive qualitative study employed 10 in-depth interviews, 2 focus group discussions and 7 key informant interviews with patients, guardians and health workers. Participants were identified through purposive sampling from Traditional Authorities Chowe and Chimwala in Mangochi district. Data analysis was done through a thematic approach. Results: Patients expressed satisfaction with the newly-introduced oral treatment for MDR-TB owing to the fewer side effects the treatment has, absence of pain from injections, desire to accomplish plans, delivery of drugs close to patients through drones, and home visits by health care workers. However, some patients highlighted barriers to adherence such as delayed food provision, and delayed transport refunds by the Malawi National Tuberculosis Control Program through its partners. Other barriers were medication stockouts, bad weather, and traveling away from home. Participants recommended that to improve adherence, interventions should include involving ex-MDR-TB patients and guardians in giving out MDR-TB adherence messages, and intensifying community sensitisation on MDR-TB. Conclusion: MDR-TB treatment non-adherence is associated with patient factors, economic factors, access to health facility factors and environmental factors. Addressing the barriers is key to preventing MDR-TB relapse and new infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.